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Abstract
Heme oxygenase-1 (HO-1) system catalyzes heme to 
biologically active products: carbon monoxide, bili-
verdin/bilirubin and free iron. It is involved in main-
taining cellular homeostasis and many physiological 
and pathophysiological processes. A growing body of 
evidence indicates that HO-1 activation may play an 
important protective role in acute and chronic inflam-
mation of gastrointestinal tract. This review focuses 
on the current understanding of the physiological sig-
nificance of HO-1 induction and its possible roles in 
the gastrointestinal inflammation studied to date. The 
ability to upregulate HO-1 by pharmacological means   
or using gene therapy may offer therapeutic strategies       
for gastrointestinal inflammation in the future. 
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Heme oxygenase (HO) is the rate-limiting enzyme in heme 
catabolism, a process which leads to the generation of  
equimolar quantities of  carbon monoxide (CO), Fe2+ and 
biliverdin. Three distinct HO isoforms (HO-1, HO-2 and 
HO-3) have been identified to date, which are the products 
of  different genes. HO-2 is constitutively and most highly 
expressed in neuronal tissues contributing to cell homeo-
stasis, whereas HO-1, also referred to as heat shock pro-
tein-32 (Hsp32), is an inducible enzyme and expressed at a  
relatively low level in most tissues    [1]. HO-3 has been found 
only in the rat brain, but no activity in humans     [2].
Unlike the constitutively expressed HO-2, HO-1 is 
exquisitely sensitive, not only to heavy metals[3], but also to  
all kinds of  stimuli and agents that cause oxidative stress 
and pathological conditions. Induction of  the HO-1 pro-
tein has been reported to protect against a variety of  stress 
conditions such as ischemia[4], hemorrhagic shock[5], heat 
4283
World J Gastroenterol  2011 October 14; 17(38): 4283-4288
 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)
© 2011 Baishideng. All rights reserved.
Online Submissions: http://www.wjgnet.com/1007-9327office
wjg@wjgnet.com
doi:10.3748/wjg.v17.i38.4283
October 14, 2011|Volume 17|Issue 38|WJG|www.wjgnet.com
Zhu X et al . HO-1 and gastrointestinal inflammation
shock[6], hypoxia[7], and reactive oxygen species (ROS)    [8].
In fact, there has been no other enzyme described to       
date that is affected by so many stimuli of  diverse nature 
as HO-1[1]. The strong adaptive response of HO-1 to       
various stimuli suggests that pharmacologic modulation   
of  HO-1 system may represent an effective and coop-
erative strategy to intervene in protection against inflam-
matory processes and oxidative tissue injury. HO-1 is 
expressed constitutively in normal gastric, intestinal and 
colonic mucosa[9,10] and up-regulated in their inflamed 
tissues[10]. What implications of  HO-1 are in gastrointes-
tinal inflammation and injury? In this review, we focus 
on this subject, and elucidated the mechanisms and some        
potential clinical applications to gastrointestinal inflam-
mation.
UPREGULATION OF HO-1 IN 
GASTROINTESTINAL TRACT
Interestingly, expression of  HO-1 is usually increased in 
gastrointestinal inflammation and injury. This was shown 
in gastric ulcers[11], colitis[12,13], radiation enteritis[14], in-
flammatory bowel disease (IBD)[15] of  animal models or 
patients. Moreover, HO-1 is expressed constitutively in 
normal gastrointestinal tract (GIT)[9,10].
The GIT is lined by a simple epithelium that sepa-
rates the hostile processes of  digestion and absorption 
that occur in the intestinal lumen from the aseptic en-
vironment of  the internal milieu by defensive mecha-
nisms.[16] GIT undergoes constant oxidative stress, in-
flammation and cell cycle/apoptosis. The normal expres-
sion and up-regulation of  HO-1 indicate that activation 
of  HO-1 could act as a natural defensive mechanism to 
alleviate inflammation and tissue injury in the GIT[13,17,18].
ROLE OF HO-1 IN GASTROINTESTINAL 
INFLAMMATION AND INJURY
HO-1 is commonly regarded as a potent anti-inflamma-
tory enzyme and has anti-inflammatory properties. For  
example, HO-1 upregulated by hemin[19], heme[20] and 
cobalt-protoporphyrin[21] can ameliorate experimental 
colitis. Conversely, administration with HO inhibitor (tin 
mesoporphyrin, SnMP) results in exacerbation of  exper-
imental colitis along with a reduction in HO-1 activity[12].
In addition, the mechanism of  action of  5-aminosali-
cylic acid (5-ASA, an anti-colitis agent used clinically) is 
attributed in part to the up-regulation of  HO-1 enzyme 
expression and activity[22]. Moreover, some agents includ-
ing glutamine [9,23], tranilast[24], RDP58[25], Octreotide[26,27], 
lansoprazole[28-30], Ketamine[31] Polaprezinc (PZ, an anti-
ulcer drug)[32] and gliotoxin[33]may contribute to the pres-
ervation of  gastrointestinal mucosa in some experimen-
tal models, such as colitis, radiation enteritis, and acute        
gastric mucosal lesions. This protective effect is partly      
mediated by the induction of  HO-1 expression. 
Nuclear factor-erythroid 2-related factor 2 (Nrf2) has 
been known to be a transcriptional factor which plays a 
crucial role in cytoprotection against inflammation. The 
severity of  colitis induced by dextran sulphate sodium 
(DSS) in Nrf2-deficient mice is found to be associated 
with decreased expression of  HO-1[34].
These results demonstrate that HO-1 may be impli-
cated in cytoprotection and may be an effective agent 
for the treatment of  diseases characterized by mucosal 
inflammation in GIT.
MECHANISMS OF ACTION
HO-1 seems to have an important protective role in ac-
ute and chronic inflammation of  GIT. HO-1 is the key 
enzyme in heme degradation and plays a key role in 
regulating the intracellular heme level. HO-1 activity 
means rapid removal of  free heme, which is shown to 
be cytotoxic. Thus, HO-1 is associated with a protective 
response and contributes to the preservation of  GIT 
mucosa (Figure 1).
CO AND GASTROINTESTINAL 
INFLAMMATION
Almost all CO produced in vivo comes from the deg-
radation of  heme by HO. Evidences indicate that CO    
mediates many of  the biological actions of  HO-1[35]. 
Otterbein et al[36] demonstrate that CO can inhibit the 
production of  proinflammatory cytokines [tumor necro-
sis factor (TNF)-α, interleukin (IL)-1β, and macrophage 
inflammatory protein-1β] and stimulate the synthesis 
of  the anti-inflammatory cytokine interleukin-10. Other 
studies also suggest that CO implicates in mediating the       
anti-inflammatory actions[37,38]. 
Hegazi et al[39] have shown that CO at a low concen-  
tration mitigates chronic intestinal inflammation in a 
T helper-type-1 cell-mediated mouse model of  murine 
colitis in IL 10-deficient mice and protect against the de-
velopment of  postoperative ileus (POI) and necrotising 
enterocolitis in rodents and swine[40-42]. Moreover, Scott 
et al[43] demonstrate that low-dose inhaled CO selectively 
attenuates the remote intestinal inflammatory response 
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Figure 1  Cytoprotective effects of heme oxygenase-1 pathway in gas-       
trointestinal inflammation. CO: Carbon monoxide; GIT: Gastrointestinal 
tract; HO-1: Heme oxygenase-1; iNOS: Inducible nitric oxide synthase; MAPK: 
Mitogen-activated protein kinase. 
elicited by hindlimb ischemia-reperfusion. And pre-treat-
ment with CO-releasing molecules (CO-RMs) markedly 
reduced intestinal muscularis inflammation induced by 
surgical manipulation of  the small intestine[44]. The anti-
inflammatory actions of  CO can be in large measure 
mediated through p38 mitogen-activated protein kinase 
(MAPK) pathway[36,37].
The knowledge of  the role of  CO in gastrointestinal 
inflammation is limited, but such a mechanism could be 
operative in GIT. Recently, Chin  et al[45] pointed out that   
CO has been ascribed an additional novel role as a host 
defense molecule agent against microbes (bactericidal 
agent).
BILIVERDIN/BILIRUBIN AND 
GASTROINTESTINAL INFLAMMATION
HO-1 catalyzes the rate-limiting step in heme degrada-
tion to biliverdin. Biliverdin is, in turn, converted into 
bilirubin by biliverdin reductase at the expense of  nico-
tinamide adenine dinucleotide phosphate (NADPH). 
Biliverdin and bilirubin are reducing species and hence 
potential antioxidants [46,47]. Several studies have dem-
onstrated that the administration of  biliverdin and/or 
bilirubin is potently cytoprotective in a variety of  patho-
physiological events, including ischemia-reperfusion in-
jury, and transplant rejection  [48,49]. In addition, bilirubin is 
also known to modulate immune effector functions and 
suppress inflammatory response[50]. 
Treatment with biliverdin can significantly decrease 
mRNA expression of  inducible nitric oxide synthase 
(iNOS), cyclooxygenase 2, and intercellular adhesion mol-
ecule-1 as well as the inflammatory cytokines IL-6 and IL-
1β, and decreased neutrophil infiltration into the jejunal 
muscularis in rat syngeneic small intestinal transplants[51]. 
Hayashi et al[52] demonstrate that the effects of  HO-1 
induction on leukocyte adhesion could be mimicked by 
bilirubin. In addition, the study of  Lee et al[53] show that 
bilirubin exerts anti-inflammatory effects in vitro.
The data indicate that this product of  HO reaction 
play an important role in the anti-inflammatory effects 
of  HO-1. However, there has been no report about the      
measurement of  tissue levels of  biliverdin/bilirubin in 
human GIT, and even the role of  the biliverdin/bilirubin 
pathway has not been clarified in experimental model of      
gastrointestinal inflammation. 
Fe2+ AND GASTROINTESTINAL
INFLAMMATION
Fe2+, the third product of  heme decomposition, can be 
potentially toxic, but it can upregulate an iron-transport-    
er pump that removes intracellular Fe2+ from the cell[54] 
and induces the expression of  ferritin, an iron storing 
protein[55]. Expression of  ferritin is originally reported 
to protect endothelial cells against oxidant damage    in 
vitro[55]. In addition, over-expression of  H-ferritin (heavy 
chain ferritin) has also been shown to protect cultured 
endothelial cells from undergoing apoptosis and protect 
livers from transplant-associated ischemia-reperfusion 
injury[56]. Increased ferritin protein levels induced by 
lansoprazole in endothelial cells and macrophages can 
reduce NADPH-dependent ROS formation, indicating     
that ferritin may account for the gastric protection of        
lansoprazole[30].
Although the roles of  the iron and ferritin in the 
overall cytoprotective effect of  HO-1 are not clear, pre-
sumably both contribute in a crucial manner to the over-
all antioxidant effect following increased HO-1 expres-
sion in a variety of  situations[57]. Further work is clearly 
needed in this area.
The exact mechanisms underlying the anti-inflamma-
tory functions of  the HO-1 in gastrointestinal inflam-
mation have not been fully elucidated. However, the 
signaling action of  CO combined/or complemented by 
the antioxidant properties of  biliverdin/bilirubin and 
the sequestration of  iron by ferritin could all contribute 
to suppression of  inflammation[58]. It becomes clear that   
upregulation of  HO-1 and/or exogenous administration 
of  one or more of  its products would be therapeutic 
strategies for gastrointestinal inflammation.
HO-1 AND iNOS
The inducible isoform of  nitric oxide synthase (iNOS) 
can produce sustained high quantities of  nitric oxide 
(NO), which may be involved in the mucosal injury asso-
ciated with IBD. Indeed, upregulation of  iNOS or NO 
release has been demonstrated in both ulcerative colitis   
and Crohn’s disease[59,60]. HO-1 inducers, cadmium and 
bismuth salts, heme, and nitric oxide (NO) donors, act at 
the transcriptional level inhibiting iNOS mRNA expres-
sion in vitro[61]. Wang et al[12] investigated the possible role    
of  HO-1 in experimental colitis in rats. Their data show 
that HO-1 plays a protective role in the colonic damage, 
and this effect probably result in part from inhibition of         
iNOS expression in colonic tissues. Moreover, Dijkstra 
et al[62] demonstrate opposite regulation of  iNOS and 
HO-1 in intestinal epithelial cells in response to cytokine 
exposure and oxidative stress. These findings suggest 
that HO-1/CO and iNOS/NO system may act together 
in a complex, dynamic, and adaptable association in 
gastrointestinal inflammation, which remain to be eluci-
dated further. 
HO-1 PROMOTER POLYMORPHISM
HO-1 is known as an oxidative stress responsive protein 
that is upregulated by multiple stimuli, which has been    
proposed to provide an important cellular response 
that protects cells against oxidative damage. However, 
humans differ quantitatively in their ability to mount an 
HO-1 response. 
An HO-1 gene promoter microsatellite (GT)(n) 
dinucleotide repeat polymorphism is associated with 
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regulation of  HO-1 in response to inflammatory stimuli. 
Short GT repeats (< 25) are associated with highly sig-
nificant up-regulation of  HO-1 in response to inflam-
matory stimuli[63,64]. The investigators have studied the     
association between the HO-1 genotype and gastroin-
testinal inflammation. They investigated the variants of    
the HO-1 promotor region in 179 patients with Crohn’s   
disease, 110 with ulcerative colitis and 56 control patients       
without inflammation. The data show that (GT)(n) di-
nucleotide repeats of  the HO-1 promotor region have no 
significance for the pathophysiology and disease course 
of  IBD[65]. In gastrointestinal tumors, a potential impact 
of  the (GT)(n) repeat polymorphism has been demon-
strated[66]. But in gastrointestinal inflammation diseases 
which usually associate tumors, it remains to be verified.
CONCLUSION
Chronic inflammatory disorders in GIT have been linked 
with an increased risk of  the development of  gastrointes-
tinal tumors[66]. It is well known that HO-1 is involved in 
inflammation and have protective effects in GIT against 
inflammation and oxidative injury; thus, the modulation 
of  HO-1 through pharmacological means or the use of  
gene therapy may offer therapeutic strategies for gastro-
intestinal inflammation and more importantly, to prevent 
gastrointestinal cancer. A comprehensive understanding 
of  the underlying mechanisms for the observed effects 
of  HO-1 in gastrointestinal inflammation will be neces-
sary in the future.
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